Ü. ŞAHİN Et Al. , "The Clinical Utility of Serum YKL-40 Levels in Community Acquired Pneumonia," J Thorac Dis , vol.5, no.5, pp.634-640, 2013
ŞAHİN, Ü. Et Al. 2013. The Clinical Utility of Serum YKL-40 Levels in Community Acquired Pneumonia. J Thorac Dis , vol.5, no.5 , 634-640.
ŞAHİN, Ü., Kayhan, S., Gümüş, A., Çınarka, H., Murat, N., Yılmaz, A., ... Bedir, R.(2013). The Clinical Utility of Serum YKL-40 Levels in Community Acquired Pneumonia. J Thorac Dis , vol.5, no.5, 634-640.
ŞAHİN, ÜNAL Et Al. "The Clinical Utility of Serum YKL-40 Levels in Community Acquired Pneumonia," J Thorac Dis , vol.5, no.5, 634-640, 2013
ŞAHİN, ÜNAL Et Al. "The Clinical Utility of Serum YKL-40 Levels in Community Acquired Pneumonia." J Thorac Dis , vol.5, no.5, pp.634-640, 2013
ŞAHİN, Ü. Et Al. (2013) . "The Clinical Utility of Serum YKL-40 Levels in Community Acquired Pneumonia." J Thorac Dis , vol.5, no.5, pp.634-640.
@article{article, author={ÜNAL ŞAHİN Et Al. }, title={The Clinical Utility of Serum YKL-40 Levels in Community Acquired Pneumonia}, journal={J Thorac Dis}, year=2013, pages={634-640} }